BSE filing, NSE: ONEPOINT. Summary written from the filing by ALFA Finder's alert engine.
One Point One Solutions Ltd: key numbers
- Share price
- ₹75.56
- Market cap
- ₹1,988 Cr
- Revenue (annual)
- ₹313.4 Cr
- Net profit (annual)
- ₹38.25 Cr
- P/E (TTM)
- 37.0×Sector 23.6×
- Promoter holding
- 52.31%+0.00% QoQ
- FII holding
- 5.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from One Point One Solutions Ltd
All →One Point One Solutions Employee Stock Options
One Point One Solutions allotted 1,45,754 equity shares to employees under its ESOS 2022 at an exercise price of ₹18.85. Paid-up capital rose to ₹52.62 crore.
One Point One Solutions Promoter Buying
Promoter Akshay Gurcharanlal Chhabra bought 3,69,155 equity shares of One Point One Solutions on November 6, 2026. The purchase was made through open market transactions and disclosed voluntarily.
One Point One Solutions Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue ₹174.96 Cr (+10.5% QoQ), EBITDA margin 25.9%, PAT ₹18.41 Cr. Margin is down YoY, blamed on acquisition timing; capex and valuation questions were deflected.
- Call
- Guides 15% growth
One Point One Solutions Investor Presentation: Key Takeaways
Q2FY27 revenue INR174.6Cr (+146.9% YoY), EBITDA INR45.3Cr (+108.6%), PAT INR18.4Cr (+86.8%). Pushes ResolX agentic AI and Resolution-as-a-Service; no numeric guidance.
One Point One Solutions Results Update
Q2 FY27 revenue was ₹174.96 crore, up 147% YoY, with PAT at ₹18.41 crore. New Costa Rica and power utility contracts were also announced.
One Point One Solutions Q2 FY27 Results: Net Profit ₹18.4 Cr, Up 85.9% YoY
One Point One Solutions Ltd reported revenue from operations of ₹175 Cr (+146.8% YoY) and net profit of ₹18.4 Cr (+85.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹18.4 Cr · +85.9% YoY
Other other announcement announcements
All →Neogen Chemicals Other Announcement
A HUF of a director of Neogen's wholly owned subsidiary sold 2,361 shares on 5-6 November 2026. Sale consideration totals about ₹0.59 crore.
- Value
- ₹0.59 Cr
Mittal Sections Other Announcement
Mittal Sections filed CARE Ratings' IPO fund monitoring report for the quarter ended September 30, 2026. No deviation from IPO objects; ₹0.32 crore unutilised.
Mehul Colours Other Announcement
Mehul Colours disclosed utilisation of IPO proceeds up to 30 September 2026, with auditor certification. No deviation from the stated objects was reported.
Capricorn Systems Global Solutions Other Announcement
Capricorn Systems reports rights issue proceeds fully utilised as of September 30, 2026, with no deviation. This is a routine Regulation 32 utilisation statement.
Thrive Future Habitats Other Announcement
Thrive Future Habitats Ltd filed its quarterly shareholding pattern for the quarter ended 30 September 2026. Note 1 records 93,12,364 shares allotted on warrant conversion, pending demat and lock-in.
Shelter Pharma Other Announcement
Shelter Pharma reports no deviation in use of Rs 2602.50 lakh warrant proceeds. The statement is certified by Alvi & Associates.